The best medical global roll out CEO working with the best child clinicians and researchers in AUS, PCK are clinical in their approach. PD has already stated app needing tweaking for rapid infant head movement, so mo the results are already known, trial would not commence otherwise. Of course this is expected, MGT would not engage in this trial any other way. Infant app a perfect diversification of the tech, congrats team PCK
PCK Price at posting:
20.0¢ Sentiment: Buy Disclosure: Held
